Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | BLM | P54132 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.46 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.46 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.44 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.44 |
| ▸ | ECE1 | P42892 | 2/20 | 0.44 |
| ▸ | BMP1 | P13497 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.40 |
| ▸ | TMPRSS15 | P98073 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alanyl Glutamine SCHEMBL31140886 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL28215332 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL1009705 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL4274839 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL8427100 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL8813935 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL133887 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL29804717 | 1.00 | NOD1 (0.59) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518502 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 | |
| Alanyl Glutamine SCHEMBL21518470 | 0.98 | NOD1 (0.58) | NOD1KMT2AALOX15BLMPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1810 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122081205-A | Fertilization culture solution and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122012392-A | NK cell culture kit and NK cell culture method using same | 广东普罗凯融生物医药科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12612600-B2 | Methods for preparing mesenchymal stem cells | ALLIFE MEDICINE (BEIJING) LIMITED (CN) | 2026-04-28 | — | — | US | claimed |
| EP-4510995-B1 | COSMETIC COMPOSITION CONTAINING A VESICULAR CONCENTRATE CONSISTING OF A WATER SOLUTION OF LIPID VESICLES FOR COSMETIC PRODUCTS, COSMETIC PRODUCTS CONTAINING SAID COSMETIC COMPOSITION AND METHOD FOR THEIR PRODUCTION | INTERCOS ITALIANA (IT) | 2026-04-15 | — | — | EP | claimed |
| EP-3991558-B1 | CELL SHEET PROTECTION SOLUTION | BOE TECHNOLOGY GROUP CO LTD (CN) | 2026-01-28 | — | — | EP | claimed |
| US-20250281668-A1 | BIOLOGICAL POLYSACCHARIDE HYDROGEL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | QINGDAO HEALTH OCEAN BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-09-11 | — | — | US | claimed |
| US-20250275531-A1 | STABILIZATION MEDIUM FOR EXTENDING TEMPORAL VIABILITY OF HUMAN SEMEN | RAMACHANDRAN ASHWIN (AU) | 2025-09-04 | — | — | US | claimed |
| US-20250257330-A1 | Multipurpose Compositions for Collecting and Transporting Biological Material | LONGHORN VACCINES AND DIAGNOSTICS, LLC (US) | 2025-08-14 | — | — | US | claimed |
| US-20250250543-A1 | METHODS FOR PREPARING MESENCHYMAL STEM CELLS | ALLIFE MEDICINE (BEIJING) LIMITED (CN) | 2025-08-07 | — | — | US | claimed |
| EP-4568500-A1 | HYDRATION COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-06-18 | — | — | EP | claimed |
| WO-2000032140-A1 | SYSTEM AND SEQUENTIAL CULTURE MEDIA FOR IN VITRO FERTILIZATION | IVF SCIENCES COLORADO, INC. (US) | 2000-06-08 | — | — | WO | claimed |
| EP-1000541-A1 | Defined serumfree medical solution for ophthalmology | Bausch & Lomb Surgical, Inc. (US) | 2000-05-17 | — | — | EP | claimed |
| EP-0595345-B1 | Process for producing alanylglutamine | KYOWA HAKKO KOGYO KK (JP) | 2000-01-12 | — | — | EP | claimed |
| CN-1166963-A | Composition containing zinc compound and p-acetaminophenyl acetic acid | XIA XIAOLIN (CN) | 1997-12-10 | — | — | CN | claimed |
| CN-1166320-A | Composite of zinc containing compound and glutamines | XIA XIAOLIN (CN) | 1997-12-03 | — | — | CN | claimed |
| EP-0571198-B1 | Cosmetic composition containing hair-growth promoter | UNILEVER PLC (GB) | 1997-03-19 | — | — | EP | claimed |
| US-5561111-A | Stable glutamine derivatives for oral and intravenous rehydration and nutrition therapy | THE UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 1996-10-01 | — | — | US | claimed |
| US-5380934-A | Process for producing alanylgutamine | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1995-01-10 | — | — | US | claimed |
| EP-0595345-A1 | Process for producing alanylglutamine | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1994-05-04 | — | — | EP | claimed |
| EP-0220379-B1 | USE OF GLUTAMINE IN THE FORM OF ITS DI- AND TRIPEPTIDE IN A NUTRIENT MEDIUM FOR CELL CULTURE | Pharmacia GmbH (DE) | 1990-05-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612600-B2 | Methods for preparing mesenchymal stem cells | ALPP, ACVR1, ALPG | NOD1 4731/4885KMT2A 988/4885ALOX15 1362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.